Neurological Sciences

, Volume 31, Supplement 1, pp 23–28

Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials

Chronic Migraine


Chronic migraine is an important public health problem. The aim of treatment should be to reduce migraine frequency and its negative impact on functioning, as well as to limit the use of acute medications. These goals may be accomplished by introducing effective prophylaxis. The aim of the present article is to critically review the published evidence on the pharmacological prophylaxis of chronic migraine, analysing published double-blind, placebo-controlled studies on adult patients. The results of the review indicate that tizanidine, gabapentin, valproic acid, and particularly topiramate are effective prophylactics against chronic migraine, with improvements in several endpoints that were significantly superior to those achieved by placebo. However, the different results found by different trials, as well as several methodological problems inherent in the trials, suggest the need for further research to provide clear indications from large, multicentre, controlled trials with homogeneous inclusion criteria and adequate endpoints.


Chronic migraine (CM) Prophylaxis Double-blind placebo-controlled trials 


  1. 1.
    Lipton RB, Bigal ME, Diamond M, AMPP Advisory Group et al (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:343–349PubMedCrossRefGoogle Scholar
  2. 2.
    Bussone G, Usai S, Grazzi L, Rigamonti A, Solari A, D’Amico D (2004) Disability and quality of life in different primary headaches: results from Italian studies. Neurol Sci 25(Suppl 3):S105–S107PubMedCrossRefGoogle Scholar
  3. 3.
    Mathew NT (1987) Transformed or evolutional migraine. Headache 27:305–306Google Scholar
  4. 4.
    Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches. Neurology 47:871–8751PubMedGoogle Scholar
  5. 5.
    Manzoni GC, Torelli P (2004) Headache classification: criticism and suggestion. Neurol Sci 25(Suppl 2):S67–S69PubMedCrossRefGoogle Scholar
  6. 6.
    Bigal ME, Lipton RB (2008) Concepts and mechanisms of migraine chronification. Headache 48:7–15PubMedCrossRefGoogle Scholar
  7. 7.
    D’Amico D, Tullo V, Cecchini AP, Usai S, Mea E, Bussone G (2008) Application of revised criteria for chronic migraine and medication overuse headache in a tertiary Headache Centre. Neurol Sci 29(Suppl 1):S158–S160PubMedCrossRefGoogle Scholar
  8. 8.
    Lipton RB (2009) Tracing transformation: chronic migraine classification, progression, and epidemiology. Neurology 72(Suppl 5):S3–S7PubMedCrossRefGoogle Scholar
  9. 9.
    Headache Classification Committee of the International Headache Society (2004) The International Classification of Headache Disorders, 2nd edn. Cephalalgia 24(Suppl 1):9–160Google Scholar
  10. 10.
    Headache Classification Committee of the International Headache Society (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742–746CrossRefGoogle Scholar
  11. 11.
    Meletiche DM, Lofland JH, Young WB (2001) Quality-of life differences between patients with episodic and transformed migraine. Headache 41:573–578PubMedCrossRefGoogle Scholar
  12. 12.
    Guitera V, Munoz P, Castillo J, Pascual J (2002) Quality of life in chronic daily headache: a study in a general population. Neurology 58:1062–1065PubMedGoogle Scholar
  13. 13.
    D’Amico D, Grazzi L, Usai S, Rigamonti A, Curone M, Bussone G (2005) Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura. Headache 45(5):553–560PubMedCrossRefGoogle Scholar
  14. 14.
    Scher AI, Stewart WF, Liberman J, Lipton RB (1998) Prevalence of frequent headache in a population sample. Headache 38(7):497PubMedCrossRefGoogle Scholar
  15. 15.
    Pascual J, Colás R, Castillo J (2001) Epidemiology of chronic daily headache. Curr Pain Headache Rep 5(6):529–536PubMedCrossRefGoogle Scholar
  16. 16.
    Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106:81–89PubMedCrossRefGoogle Scholar
  17. 17.
    Katsarava Z, Schneeweiss S, Kurth T et al (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62:788–790PubMedGoogle Scholar
  18. 18.
    Fragoso YD, Carrazana EJ (2000) Low doses of gabapentin may be helpful in the management of chronic daily headache. MedGenMed 2:E52PubMedGoogle Scholar
  19. 19.
    Spira PJ, Beran RG, Australian Gabapentin Chronic Daily Headache Group (2003) Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology 61:1753–1759PubMedGoogle Scholar
  20. 20.
    Saper JR, Lake AE III, Cantrell DT, Winner PK, White JR (2002) Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache 2:470–482CrossRefGoogle Scholar
  21. 21.
    Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl 7):1–96Google Scholar
  22. 22.
    Freitag FG, Diamond S, Diamond ML, Urban GJ (2001) Divalproex in the long-term treatment of chronic daily headache. Headache 41:271–278PubMedCrossRefGoogle Scholar
  23. 23.
    Mathew NT, Ali S (1991) Valproate in the treatment of persistent chronic daily headache. An open label study. Headache 31:71–74PubMedCrossRefGoogle Scholar
  24. 24.
    Rothrock JF (1999) Management of chronic daily headache utilizing a uniform treatment pathway. Headache 39:650–653PubMedCrossRefGoogle Scholar
  25. 25.
    Rothrock JF, Mendizabal JE (2000) An analysis of the ‘‘carryover effect’’ following successful short-term treatment of transformed migraine with divalproex sodium. Headache 40(1):17–19PubMedCrossRefGoogle Scholar
  26. 26.
    Yurekli VA, Akhan G, Kutluhan S, Uzar E, Koyuncuoglu HR, Gultekin F (2008) The effect of sodium valproate on chronic daily headache and its subgroups. J Headache Pain 9:37–41PubMedCrossRefGoogle Scholar
  27. 27.
    Mathew NT, Kailasan J, Meadors L (2002) Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Headache 42:796–803PubMedCrossRefGoogle Scholar
  28. 28.
    Bartolini M, Silvestrini M, Taffi R et al (2005) Efficacy of topiramate and valproate in chronic migraine. Clin Neuropharmacol 28:277–279PubMedCrossRefGoogle Scholar
  29. 29.
    Peres MF, Mercante JF, Tanuri FC et al (2006) Chronic migraine prevention with topiramate. J Headache Pain 7:185–187PubMedCrossRefGoogle Scholar
  30. 30.
    Mei D, Ferraro D, Zelano G et al (2006) Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine. Clin Neuropharmacol 29:269–275PubMedCrossRefGoogle Scholar
  31. 31.
    Silvestrini M, Bartolini M, Coccia M, Baruffali R et al (2003) Topiramate in the treatment of chronic migraine. Cephalalgia 23:820–824PubMedCrossRefGoogle Scholar
  32. 32.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group (2007) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27:814–823PubMedCrossRefGoogle Scholar
  33. 33.
    Silberstein S, Lipton RB, Dodick DW et al (2007) Efficacy and safety of topiramate in the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 47:170–180PubMedCrossRefGoogle Scholar
  34. 34.
    Diener HC, Dodick DW, Goadsby PJ, Bigal ME, Bussone G, Silberstein SD, Mathew N, Ascher S, Morein J, Hulihan JF, Biondi DM, Greenberg SJ (2009) Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia 29(10):1021–1027PubMedCrossRefGoogle Scholar
  35. 35.
    Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J (2009) Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures. Headache 49(8):1153–1162PubMedCrossRefGoogle Scholar
  36. 36.
    D’Amico D, Leone M, Grazzi L, Bussone G (2008) When should “chronic migraine” patients be considered “refractory” to pharmacological prophylaxis? Neurol Sci 29(Suppl 1):S55–S58PubMedCrossRefGoogle Scholar
  37. 37.
    Mathew NT (2009) Dynamic optimization of chronic migraine treatment: current and future options. Neurology 72(Suppl 5):S14–S20PubMedCrossRefGoogle Scholar
  38. 38.
    Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB (2004) Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes. Cephalalgia 24:483–490PubMedCrossRefGoogle Scholar
  39. 39.
    Freitag FG, Lake A 3rd, Lipton R et al (2004) US Headache Guidelines Consortium, Section on Inpatient Treatment Chairpersons. Inpatient treatment of headache: an evidence-based assessment. Headache 44:342–360PubMedCrossRefGoogle Scholar
  40. 40.
    Katsarava Z, Muessig M, Dzagnidze A et al (2005) Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 25:12–1539PubMedCrossRefGoogle Scholar
  41. 41.
    Andrasik F, Grazzi L, Usai S, D’Amico D, Kass S, Bussone G (2007) Disability in chronic migraine with medication overuse: treatment effects at 3 years. Headache 47(9):1277–1281PubMedCrossRefGoogle Scholar
  42. 42.
    Zwart JA, Dyb G, Hagen K, Svebak S, Holmen J (2003) Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology 22,61(2):160–164Google Scholar
  43. 43.
    Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB (2008) Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48(8):1157–1168PubMedCrossRefGoogle Scholar
  44. 44.
    Zeeberg P, Olesen J, Jensen R (2006) Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 26:1192–1198PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.U.O. Neurologia III-CefaleeFondazione IRCCS Istituto Neurologico C. BestaMilanItaly

Personalised recommendations